Sunitinib for the treatment of patients with advanced pheochromocytomas or paragangliomas: The phase 2 non-randomized SUTNET clinical trial

Authors:

Abstract
No abstract available
Funding Information
  • Pfizer

This publication has 45 references indexed in Scilit: